Broadleaf Partners LLC Takes $2.88 Million Position in Danaher Co. (DHR)

Broadleaf Partners LLC acquired a new position in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 30,990 shares of the conglomerate’s stock, valued at approximately $2,876,000. Danaher makes up about 2.4% of Broadleaf Partners LLC’s portfolio, making the stock its 16th largest position.

Other large investors have also bought and sold shares of the company. GQG Partners LLC bought a new stake in Danaher during the second quarter worth about $101,000. Zions Bancorporation raised its holdings in Danaher by 118.3% in the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after buying an additional 667 shares during the last quarter. Monetary Management Group Inc. raised its holdings in Danaher by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after buying an additional 150 shares during the last quarter. Acrospire Investment Management LLC raised its holdings in Danaher by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after buying an additional 1,100 shares during the last quarter. Finally, Motco raised its holdings in Danaher by 8.8% in the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after buying an additional 163 shares during the last quarter. 76.05% of the stock is currently owned by institutional investors and hedge funds.

In other Danaher news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction that occurred on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total transaction of $960,693.96. Following the completion of the sale, the director now directly owns 104,621 shares of the company’s stock, valued at $9,501,679.22. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 273,810 shares of company stock valued at $25,218,813. 12.20% of the stock is owned by corporate insiders.

Several brokerages have issued reports on DHR. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a report on Friday. Cowen reaffirmed a “buy” rating and issued a $90.00 target price on shares of Danaher in a report on Wednesday, October 4th. Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Evercore ISI began coverage on shares of Danaher in a report on Wednesday, January 3rd. They issued an “outperform” rating for the company. Finally, Royal Bank of Canada reaffirmed a “hold” rating and issued a $96.00 target price on shares of Danaher in a report on Thursday, January 4th. One research analyst has rated the stock with a sell rating, six have given a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $94.91.

Danaher Co. (NYSE DHR) traded up $0.35 on Friday, hitting $98.59. 2,026,300 shares of the stock traded hands, compared to its average volume of 2,595,313. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Co. has a 1 year low of $78.97 and a 1 year high of $98.88. The stock has a market capitalization of $69,180.00, a PE ratio of 29.34, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher had a net margin of 13.36% and a return on equity of 11.29%. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same period in the previous year, the company earned $0.87 earnings per share. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. equities analysts predict that Danaher Co. will post 3.99 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be issued a dividend of $0.14 per share. The ex-dividend date is Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.57%. Danaher’s dividend payout ratio is currently 16.67%.

WARNING: This piece of content was reported by Stock Observer and is owned by of Stock Observer. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.thestockobserver.com/2018/01/12/broadleaf-partners-llc-takes-2-88-million-position-in-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply